Device / Technology News

RSS

Winner of 2010 European Magnetic Resonance Award

Dr John Griffiths, a Cancer Research UK-funded scientist, has received the 2010 European Magnetic Resonance Award for Basic Sciences.

20 Mar 2010

LiftSeat to distribute Hygie Hygienic Cover Systems in the U.S.

LiftSeat Corporation, a leading healthcare toileting solutions company, is now the exclusive distributor in the United States of the Hygie Hygienic Cover System, which is proven to help prevent the spread of potentially fatal healthcare-associated infections. The joint announcement was made today at the Fifth Decennial International Conference on Healthcare-Associated Infections 2010.

20 Mar 2010

China Sky One Medical's Myocardial Infarction and Urine Microalbumin Diagnostic Kits receive CE certification

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China, today announced the receipt of Conformite Europeenne (CE) certification for its Myocardial Infarction and Urine Microalbumin Diagnostic Kits. The CE marking certifies that the two products have met the European Union health and safety standards and are approved for sale in the 27 EU countries and four members of the European Free Trade Association.

20 Mar 2010

New Virtuoso LigoLab interface to be demonstrated at USCAP Annual Meeting

BioImagene, Inc., the leading provider of end-to-end digital pathology solutions, and LigoLab, innovative provider of clinical laboratory information system, today announced the development of an interface between Virtuoso™, BioImagene’s digital pathology workflow software, and LigoLab’s anatomic pathology module of laboratory information system (LIS). The new interface gives labs using Virtuoso and LigoLab shared access to critical information and functionality from both systems, optimizing the clinical workflow.

20 Mar 2010

SoCalBio to host forum on latest medical devices for treating obesity

The Southern California Biomedical Council will host a discussion on the latest medical devices for treating obesity during its networking forum on Thursday, March 25th (7:00 - 9:30 am) at the UC Irvine University Club.

20 Mar 2010

Novus Scientific's TIGR Matrix Surgical Mesh: Initial results of First-in-Man study

Novus Scientific Pte. Ltd today announced the presentation of initial results of the First-in-Man study for TIGR™ Matrix Surgical Mesh. The study results were presented today at the American Hernia Society Meeting in Orlando, Florida by Dr. Fernando Ruiz-Jasbon, Consultant Surgeon at Kungsbacka Hospital / Gothenburg University, Sweden.

20 Mar 2010

Bovie Medical receives FDA marketing clearance for BOSS bipolar sintered steel coagulation device

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced the Company received clearance from the Food and Drug Administration (FDA) to market its proprietary BOSS™ bipolar sintered steel coagulation device. The BOSS™ is the latest device based on Bovie’s saline enhanced sintered steel technology.

19 Mar 2010

Comprehensive community-based solution to help achieve 'meaningful use'

Navigating the Challenges of Meaningful Use to Identify Benefits, March 31, 2010, 2 p.m. CT, a Webinar hosted by Informatics Corporation of America, will explore how to practically implement a community-wide solution that assists its healthcare participants to achieve the proposed American Recovery and Reinvestment Act’s criteria for meaningful use and bridge gaps in the adoption of electronic health records by its provider community.

19 Mar 2010

Reese Pharmaceutical chooses SYSPRO ERP for private labeling and distribution operations

SYSPRO, the leading provider of visionary, pragmatic ERP software, today announced that Reese Pharmaceutical Company has selected SYSPRO ERP (Enterprise Resource Planning) software to run its private labeling and distribution operations. Reese, based in Cleveland, Ohio, has been in business for more than a century.

19 Mar 2010

Cedars-Sinai Neurovascular Center's clinical trial of minimally invasive stenting procedure for TIA

Individuals between 30 and 80 years of age, who have had a transient ischemic attack (TIA) or non-severe stroke within the past 30 days, and who cannot be treated surgically, may be eligible to participate in a Phase III clinical trial of a minimally invasive stenting procedure at the Cedars-Sinai Neurovascular Center. The study will focus specifically on patients who have had an intracranial artery narrowed by at least 70 percent and who are experiencing recurrent strokes or TIAs despite being on anti-clotting medication.

19 Mar 2010

CIO Healthcare Summit to be sponsored by Zanett Healthcare

Zanett Healthcare is pleased to announce that it will sponsor the CIO Healthcare Summit, a leading gathering for CIOs, analysts and industry-thought leaders within healthcare information technology. The CIO Healthcare Summit will be held at the InterContinental Montelucia Resort in Scottsdale, Arizona on May 9-12, 2010.

19 Mar 2010

Maxine Morgan Eyewear unveils comprehensive line of specialized lenses, frames and specialty products

Maxine Morgan Eyewear unveils its comprehensive line of specialized lenses, frames and specialty products with a major presence here at the International Vision Expo East, booth # MS1060, medical science pavilion, in the Jacob K. Javits Convention Center.

19 Mar 2010

Hip-hop and neuroscience

The tweets flew fast and furious at the famous South By Southwest Music, Film, & Interactive Festival in Austin, Texas when "Listen To Your Brain" began playing on the big screen.

19 Mar 2010

White paper describes health and economic burden of diabetes on Americans

PositiveID Corporation announced today that it has published a white paper entitled “Fixing the Black Hole in Diabetes Management,” which describes the health and economic burden of diabetes on Americans and our economy.

19 Mar 2010

Studies reveal increased polyp detection rates with TER during colonoscopy

Two new studies show an increase in polyp detection rates using the Third Eye Retroscope (TER), a retrograde viewing device, during colonoscopy. The first study found that TER added to standard colonoscopy detected 13.2 percent more polyps than colonoscopy alone, including 11 percent additional adenomas (precancerous polyps). A second study examined endoscopist experience using TER and its impact on polyp detection rates, concluding that polyp detection rates improved significantly with TER.

19 Mar 2010

Providence receives U.S. patent for CPMMS

Providence today announces the receipt of a United States Patent for the Comprehensive Particulate Matter Measurement System (CPMMS) and the Methodology for its Use. Yousheng Zeng, PhD, PE, a principal of Providence, is the inventor of this system. Dr. Zeng explains, "Unlike current methods of monitoring air-borne particulate matter (PM), the CPMMS monitors the portion of PM that can reach and deposit in a human respiratory system."

19 Mar 2010

New report on the state of U.S. mobile health market

CSMG, the strategy division of TMNG Global, a leading provider of professional services, products and services to the converging communications, media and entertainment industries, today released its report on the state of the U.S. mobile health market, entitled: mHealth: Taking the Pulse.

19 Mar 2010

Mini-laboratory: IVD platform to be presented at Analytica trade show

Many illnesses can be reliably diagnosed through laboratory tests, but these in vitro analyses often use up valuable time. A system developed by Fraunhofer research scientists, which can carry out complex analyses on the spot, will soon be ready for the market.

19 Mar 2010

Fraunhofer FIT to present IMIKRID and automated protein-level microscope system at HANNOVER MESSE

Proteins, the cellular building blocks, can be visualized and analyzed in great detail today. Here, Fraunhofer FIT presents a fully automated high-performance microscope. One of its diagnostic applications will be to study the complex interactions of proteins between cells. In tumor diagnostics our microscope allows to classify slightly different types of tumors more precisely and to fine-tune therapy accordingly.

19 Mar 2010

Global halt on Molybdenum-99 production: Discussion of implications

Discuss the severe Tc-99m shortage that will occur over a two-week period when cancer, heart and brain disease patients will experience delayed imaging tests because of a worldwide halt on Molybdenum-99 production

19 Mar 2010